Of the sinus decongestants on the market, there are both over-the-counter and prescription strength varieties available. Patients who familiarize themselves with the basic chemical formulations that form the majority of sinus decongestants will be better able to make an informed decision about which sinus decongestant offers the best outcome.
Brooksville, Florida — September 10, 2012
According to leading pharmaceutical company MCR American Pharmaceuticals there are three types of sinus decongestants: Pseudoephedrine, Phenylpropanolamine and Phenylephrine. The company explains each type.
Firstly, pseudoephedrine is one of the most popular nasal and sinus decongestants on the market, according to MCR American Pharmaceuticals. Many popular brand names including Maxifed, Maxifed DMX, Maxifed-G, Maxifed DM, Super-Tuss PSE, and Sudafed are made with pseudoephedrine. The medication works by shrinking the blood vessels in the nasal cavity, relieving pressure on the sinus area. Medications that include pseudoephedrine may cause restlessness, insomnia, dizziness, loss of appetite, racing heartbeat and increased blood pressure.
Next, phenylpropanolamine is the second-leading sinus decongestant ingredient, according to MCR American Pharmaceuticals. Phenylpropanolamine is a constrictive sinus decongestant that has also been linked to a loss of appetite. The ingredient can also be found in some diet pills, although its primary effect is in the sinuses. Common side effects of phenylpropanolamine include dizziness, changes in blood pressure and drowsiness.
Lastly, Maxiphen and Maxiphen DM are two names commonly associated with the sinus decongestant phenylephrine, according to MCR American Pharmaceuticals. As a basic sinus decongestant, it works by shrinking blood vessels. Some of its side effects include burning or stinging in the nasal passages, dizziness, and headaches.
Prior to selecting a sinus decongestant, MCR American Pharmaceuticals recommends that patients study and ask questions about each type of sinus decongestant. Each type may affect a patient in a different way and so it’s important to familiarize oneself with as much information in order to make an informed decision.
MCR American Pharmaceuticals was founded by Jack Reagin in 1991 in Birmingham, AL and quickly expanded to several states in the Southeast. In 1999, MCR American Pharmaceuticals was purchased by David Ambrose and was relocated to Brooksville, FL. In 2008, MCR American Pharmaceuticals was acquired by Neuro-HiTech. Today, the company operates directly with medical professionals and patients in order to reduce its medicines’ prices and in order to provide better customer service.
For additional information, interview and image request contact VirtuosOnline.